Pharmacological classification of histamine H3 receptor agents across species is attributable to transmembrane 3 sequence differences

被引:6
作者
Esbenshade, T. A. [1 ]
Estvander, B. R. [1 ]
Miller, T. R. [1 ]
Baranowski, J. L. [1 ]
Sharma, R. [1 ]
Hancock, A. A. [1 ]
Krueger, K. M. [1 ]
机构
[1] Abbott Labs, Global Pharmaceut Res & Dev, Dept R4MN, Abbott Pk, IL 60064 USA
关键词
Histamine; Inverse Agonism; GTPgS Binding; Radioligand Binding Assay; Competition Binding Assay;
D O I
10.1007/s00011-006-0522-x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
引用
收藏
页码:S45 / S46
页数:2
相关论文
共 6 条
[1]  
ESBENSHADE T, 2000, CURR PROT PHARM, V1
[2]   Histamine H3 receptor antagonists:: Preclinical promise for treating obesity and cognitive disorders [J].
Esbenshade, TA ;
Fox, GB ;
Cowart, MD .
MOLECULAR INTERVENTIONS, 2006, 6 (02) :77-88
[3]   Pharmacological properties of ABT-239 [4-(2-{2-[(2R)-2-methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]:: I.: Potent and selective histamine H3 receptor antagonist with drug-like properties [J].
Esbenshade, TA ;
Fox, GB ;
Krueger, KM ;
Miller, TR ;
Kang, CH ;
Denny, LI ;
Witte, DG ;
Yao, BB ;
Pan, LP ;
Wetter, J ;
Marsh, K ;
Bennani, YL ;
Cowart, MD ;
Sullivan, JP ;
Hancock, AA ;
Esbenshade, T .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2005, 313 (01) :165-175
[4]   The histamine H3 receptor:: From gene cloning to H3 receptor drugs [J].
Leurs, R ;
Bakker, RA ;
Timmerman, H ;
de Esch, IJP .
NATURE REVIEWS DRUG DISCOVERY, 2005, 4 (02) :107-U18
[5]   Distinct pharmacology of rat and human histamine H3 receptors:: role of two amino acids in the third transmembrane domain [J].
Ligneau, X ;
Morisset, S ;
Tardivel-Lacombe, J ;
Gbahou, F ;
Ganellin, CR ;
Stark, H ;
Schunack, W ;
Schwartz, JC ;
Arrang, JM .
BRITISH JOURNAL OF PHARMACOLOGY, 2000, 131 (07) :1247-1250
[6]   Molecular modeling and pharmacological analysis of species-related histamine H3 receptor heterogeneity [J].
Yao, BB ;
Hutchins, CW ;
Carr, TL ;
Cassar, S ;
Masters, JN ;
Bennani, YL ;
Esbenshade, TA ;
Hancock, AA .
NEUROPHARMACOLOGY, 2003, 44 (06) :773-786